The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price. Do they really matter, though?Before we discuss the reliability of brokerage recommendations and how to use them to your advantage, let's see what these Wall Street heavyweights think about Baidu Inc. (BIDU) .Baidu Inc. currently has an average brokerage ...

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?Let's take a look at what these Wall Street heavyweights have to say about Agnico Eagle Mines (AEM) before we discuss the reliability of brokerage recommendations and how to use them to your advantage.Agnico currently has an average brokerage recommendati ...

For the quarter ended May 2025, Commercial Metals (CMC) reported revenue of $2.02 billion, down 2.8% over the same period last year. EPS came in at $0.74, compared to $1.02 in the year-ago quarter.The reported revenue represents a surprise of +0.49% over the Zacks Consensus Estimate of $2.01 billion. With the consensus EPS estimate being $0.85, the EPS surprise was -12.94%.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine t ...

FactSet Research (FDS) reported $585.52 million in revenue for the quarter ended May 2025, representing a year-over-year increase of 5.9%. EPS of $4.27 for the same period compares to $4.37 a year ago.The reported revenue represents a surprise of +0.72% over the Zacks Consensus Estimate of $581.34 million. With the consensus EPS estimate being $4.31, the EPS surprise was -0.93%.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall St ...

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price. Do they really matter, though?Before we discuss the reliability of brokerage recommendations and how to use them to your advantage, let's see what these Wall Street heavyweights think about Okta (OKTA) .Okta currently has an average brokerage recommendati ...

Core Insights - C3.ai, Inc. is focusing on a go-to-market strategy that leverages its expanding partner ecosystem, achieving 73% of agreements through strategic partners in Q4 of fiscal 2025 [1][9] - The company signed 193 deals through its partner ecosystem in fiscal 2025, marking a 68% increase from the previous year [1][9] - In Q4, C3.ai experienced a 419% increase in partner-supported bookings, closing 59 agreements through strategic alliances [1][2][9] Partner Ecosystem - C3.ai closed 59 partner-led deals in the fiscal fourth quarter, with a significant focus on its alliance with Microsoft, which included 28 joint deals emphasizing manufacturing and chemicals [2][9] - The company is targeting over 600 accounts in collaboration with Microsoft and is also expanding partnerships with AWS, Google Cloud, and consulting firms like PwC and McKinsey QuantumBlack [4][9] Revenue and Investment - To support its channel-centric strategy, C3.ai has invested in demo licenses and enablement tools, which accounted for nearly 30% of its Q4 revenues [3] - The management is optimistic about the potential of consulting partners to enhance scalability and market penetration in future periods [4] Competitive Landscape - Compared to C3.ai, Palantir Technologies Inc. follows a more vertically integrated model, focusing on direct client engagement rather than a partner-led sales approach [5] - Snowflake Inc. is adopting a hybrid model that combines direct go-to-market strategies with strong platform partnerships, enhancing its offerings in the public sector [6][7] Financial Performance - C3.ai's shares have increased by 0.5% over the past three months, slightly outperforming the industry growth of 0.3% [8] - The company trades at a forward price-to-sales ratio of 6.50X, significantly lower than the industry average of 18.47X [11] - The Zacks Consensus Estimate for C3.ai's fiscal 2026 and 2027 earnings per share (EPS) indicates a year-over-year increase of 9.8% and 56.9%, respectively [12]

Here are three stocks with buy ranks and strong growth characteristics for investors to consider today June 23rd:Great Lakes Dredge & Dock (GLDD) These company which is the largest provider of dredging services in the US conducting business to maintain and deepen shipping channels, reclaim land from the ocean, and renourish storm damaged coastline, carries a Zacks Rank #1 (Strong Buy), and has witnessed the Zacks Consensus Estimate for its current year earnings increasing 39.1% over the last 60 days.Great L ...

Key Takeaways UGI's AmeriGas is selling Hawaii propane assets to Isle Gas, with closing expected in Q4 fiscal 2025. The deal includes 750,000 gallons of storage and a delivery fleet, with proceeds used to reduce debt. UGI aims to boost efficiency and fund growth by exiting non-core markets and cutting long-term costs.UGI Corporation (UGI) announced that its subsidiary, AmeriGas Propane, L.P. (AmeriGas), has entered into a definitive agreement to divest some of its assets in Hawaii to Isle Gas, a wholly ow ...

Core Insights - Johnson & Johnson (J&J) received a positive recommendation from the EMA's CHMP for label expansions of its drugs Darzalex and Imbruvica for new indications [1][8] Group 1: Darzalex - The CHMP recommended expanding Darzalex's label to treat adults with high-risk smoldering multiple myeloma (SMM) [2][4] - If approved, Darzalex will be the first therapy for this patient population, which is currently managed through active monitoring [3] - The decision is supported by data from the phase III AQUILA study, showing significant reduction in the risk of progression or death compared to active monitoring [4] - Darzalex sales increased by 20% year over year to $3.24 billion in Q1 2025, driven by market share gains [5] Group 2: Imbruvica - The CHMP also recommended Imbruvica for treating adults with previously untreated mantle cell lymphoma (MCL) eligible for autologous stem cell transplant [9][10] - If approved, Imbruvica could be the first BTK inhibitor for this indication, potentially offering long remissions without the burden of transplant [10] - The recommendation is based on the TRIANGLE study, which demonstrated improved overall survival with Imbruvica plus chemotherapy [11] - J&J markets Imbruvica in partnership with AbbVie, sharing commercial responsibilities in the U.S. and international profits [12] Group 3: Stock Performance - J&J's stock has risen nearly 4% year to date, outperforming the industry, which has seen a 3% decline [6]

Have you evaluated the performance of Accenture's (ACN) international operations for the quarter ending May 2025? Given the extensive global presence of this consulting company, analyzing the patterns in international revenues is crucial for understanding its financial strength and potential for growth.In the current era of a tightly interconnected global economy, the proficiency of a company to penetrate international markets significantly influences its financial health and trajectory of growth. For inves ...